Zimmer Durom Cup Hip Replacement
Motley Rice is currently accepting cases in which recipients of the Zimmer Durom® cup have suffered intense pain or injuries following hip replacement surgery.
If you or someone you know has experienced severe pain or other injuries after the implantation of a Zimmer Durom hip replacement device, contact attorney John Duane by email or call 1.800.768.4026.
Durom Cup Lawsuits
On June 9, 2010, the United States Judicial Panel on Multidistrict Litigation issued an order approving centralization of products liability cases involving the Zimmer Durom Cup hip device. The MDL will be centralized in the District of New Jersey and has been assigned to the Honorable Susan D. Wigenton. This litigation currently consists of 45 actions: 33 pending in the District of New Jersey, four in the Western District of Louisiana, two in the Southern District of Ohio, two in the Eastern District of Texas, and one each in the District of Arizona, the Northern District of Illinois, and the Western District of Kentucky.
Click here to read the order.
Durom Cup Sales Suspended
In July 2008, Zimmer, Inc., voluntarily suspended the sale of the Durom Hip Resurfacing System in the United States after physicians expressed concern over a high failure rate with the hip replacement device.
The reports indicate that the Durom cup may fail to fuse properly with the bone, instead separating and migrating in the body. When the Durom cup moves, it pushes the metal hip socket against bone, which can cause excruciating pain for patients. Additionally, problems with the Durom cup may require patients to undergo hip revision surgeries, medical monitoring or rehabilitation.
Ongoing Concerns with the Durom Cup
There has been controversy surrounding whether the benefit of metal hip implants outweighs the potential risks. In June 2012, the FDA held a two-day advisory panel meeting to discuss how to monitor the more than half-million U.S. patients with metal hip replacements given the results of recent studies and the thousands of adverse reports the FDA has received in connection to the devices. Metal-on-metal devices were originally thought to be a more durable alternative to ceramic or plastic models, but some foreign studies have shown that they may deteriorate faster, expose patients to high levels of metals such as cobalt and chromium, and fail at a higher rate than older implants. According to a report by The Associated Press, the FDA "has asked manufacturers like Johnson & Johnson, Zimmer Holdings Inc. and Biomet Inc. to conduct long-term, follow-up studies of more than 100 metal-on-metal hips on the U.S. market."
Since 2006, the Durom cup has been implanted in nearly 13,000 patients.
According to the New York Times, veteran orthopedic surgeon Dr. Lawrence Dorr first told Zimmer about his concerns with the Durom hip replacement cup in early 2008. The manufacturer did not investigate the issue until Dr. Dorr raised his concerns with the American Association of Hip and Knee Surgeons. Zimmer subsequently suspended sales of the Durom cup, indicating that up to 5.7% of the implanted Durom cups may need to be replaced in the United States and Europe.